Cite
HARVARD Citation
Kort, J. et al. (2020). Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma. Leukemia & lymphoma. 61 (7), pp. 1732-1735. [Online].